Founded with the mission to revolutionize disease diagnostics, Unima focuses on providing rapid, low-cost diagnostic solutions and real-time disease surveillance. Their innovative technology allows for the diagnosis of diseases directly at the point of care, without the need for lab equipment, delivering results in just 15 minutes. This approach aims to enhance accessibility and efficiency in healthcare, particularly in underserved and remote areas.
Unima has garnered attention from notable investors and healthcare professionals for its groundbreaking work. The company's achievements include significant advancements in diagnostic technology and successful implementation in various regions, improving healthcare outcomes. Unima's impact is evident in its ability to provide timely and accurate disease tracking, ultimately contributing to better public health management globally.
